Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01760863 · ClinicalTrials.gov registry record · NA

Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty

A NA study, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
185
Enrollment target

NCT01760863 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 185 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01760863, a NA study, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
185 participants
Enrollment target

Study Summary

The primary purpose of this study is to compare the re-infection rates in patients undergoing 2-stage revision arthroplasty who receive additional oral antibiotic therapy to those patients who received in-hospital perioperative antibiotic only. Patients will be monitored for re-infection following hospital discharge, defined as deep infection of the joint space/capsule that requires return to the operating room within 24-months of the re-implantation procedure.

Interventions

  • OTHER Oral Antibiotics

Trial Details

FieldValue
Enrollment Target 185 participants
Start Date 2011-07
Est. Completion 2020-09-23
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT01760863

The ClinicalTrials.gov registry entry for NCT01760863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Oral Antibiotics is the first listed.

NCT01760863 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01760863 about?

NCT01760863 is a clinical study titled "Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty". The primary purpose of this study is to compare the re-infection rates in patients undergoing 2-stage revision arthroplasty who receive additional oral antibiotic therapy to those patients who received in-hospital perioperative antibiotic only. Patients will be monitored for re-infection following h...

What is the current status of trial NCT01760863?

This trial is currently completed. It is a NA study. The enrollment target is 185 participants. The study started on 2011-07. Estimated completion is 2020-09-23.

What interventions are being tested in trial NCT01760863?

The interventions under investigation include: Oral Antibiotics (OTHER).

Who is sponsoring clinical trial NCT01760863?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.